There is no increased risk of blood clotting post vaccination with Covaxin and Covishield so far, ruled top government committee. The top committee came to the finding post analyzing more than 400 adverse reactions encountered during ongoing vaccination drive in India.  Dr NK Arora, executive director of the INCLEN Trust and an advisor to the ...

With 1 million COVID-19 shots in just 6 days, India’s vaccination drive becomes the world’s fastest The Indian government has vaccinated nearly 16 lakh people against COVID-19 since the launch of its mass inoculation drive on January 16. According to the Health Ministry, authorities have administered approximately 10 lakh vaccine shots in just six days, ...

India started its vaccination drive on January 16 and a week later, the country has administered more than one million vaccine shots to people against Covid-19 virus. With this achievement, India has become the fastest country to cross the mark of a million doses among all the countries that have started the vaccination drive.  The ...

Oxford’s COVID-19 vaccine: After UK approved Oxford-AstraZeneca’s COVID-19 vaccine, India is likely to have its vaccine soon Britain’s approval of the Oxford-AstraZeneca COVID-19 vaccine for emergency use has given new hopes to India’s efforts to fight the rising cases in the country. As per media reports, Indian regulators are expected to hold further meetings in ...

Russia’s Sputnik: India has nearly five vaccines for coronavirus under its belt and with the announcement of production of 100 million vaccine doses of Russia’s covid-19 vaccine Sputnik V, India looks at extending its list even more.  It is combine effort of three institution which include the Russian Direct Investmnet Fund, Russia’s sovereign wealth funf ...

Mission Covid Suraksha: The Indian government launched a new initiative in the wake of the coronavirus pandemic called ‘Mission Covid Suraksha’ on Wednesday. This initiative will facilitate the development process of nearly five to six vaccine candidates in the country which means the procedure will be accelerated.  Through this project, it will be easier for ...

Congress leader Rahul Gandhi on Sunday condemned the Union Government’s handling of the COVID-19 crisis in India. Taking to Twitter, he shared a BBC video showing how India responded to the pandemic crisis. The video briefed about various aspects of India’s response to COVID-19 ranging from the plight of migrant workers after a nationwide lockdown ...

India is looking for successfully performing covid-19 vaccine candidate all across the world to strike a deal with the best ones. So far, India’s list of possible acquisitions include the under-trail candidates being developed by UK’s Oxford-AstraZeneca and United States’s Moderna-NIAID. Besides, the government is also closely observing the progress of vaccine candidates being developed ...

India will be using a digital infrastructure for the dissemination and inventory management of the novel Covid-19 virus vaccine once it becomes available. It is also devising a fool proof method of procurement including both indigenous and international. This will also include guiding principles to prioritize focus groups. The national expert group on vaccine administration ...

As the race across nations intensifies to come up with a vaccine to the Covid-19 virus, India is now moving ahead with its plans to give quick approvals to the Serum Institute of India that is now reaching its Phase 3 of vaccine trials. On trial is the promising Covid-19 vaccine that has been developed ...